Breast cancer is a highly heterogeneous disease. Clinical and pathological classifications have long been used to guide patient treatment. Although classic histopathological classification remains important, molecular characterization of breast cancer has rapidly become an important tool for understanding clinical prognosis and predicting chemotherapy efficacy. Classical histopathological grading Based on cell morphology, breast cancer is usually divided into tumors that originate from ductal cells (ductal adenocarcinoma) or lobules (lobular carcinoma). Breast malignancies are further divided into invasive cancers that can metastasize (invasive carcinoma) and non-invasive cancers confined to the basement membrane (ductal carcinoma in situ, i.e. intraductal carcinoma). 1. Ductal adenocarcinoma is the most common tissue type. The clinical prognosis varies widely, from indolent to rapidly progressive. The prognosis can be assessed by cell morphological characteristics and the expression of molecular markers such as ER, HER2, Ki67 and HER2. 2. Lobular carcinoma Lobular carcinoma in situ (LCIS) can increase the risk of developing invasive cancer (ductal carcinoma or lobular carcinoma) in the future. However, LCIS itself has no clinical consequences. Similar to invasive ductal carcinoma, invasive lobular carcinoma can metastasize, and its stage is related to prognosis. The diagnosis of invasive lobular carcinoma is particularly difficult due to the unique single-cell radial invasion pattern, which often results in negative findings on palpation or breast imaging. Compared with invasive ductal carcinoma, invasive lobular carcinoma tends to occur bilaterally and is prone to metastasize to the pleuropericardial surface. 3. Special subtypes with better prognosis include papillary, tubular, mucinous and medullary carcinomas. 4. Inflammatory breast cancer is a highly invasive subtype. Invasion of the skin lymphatic vessels can be observed under a microscope, which confirms the diagnosis. Clinically, it is often accompanied by breast skin erythema (similar to mastitis) and skin edema, also known as "orange peel-like lesions." 5. Paget's disease of the breast is characterized by unilateral nipple eczematous changes, often accompanied by ductal carcinoma in situ. 6. Cystosarcoma phyllodes is very rare and mostly benign, accounting for less than 1% of all breast tumors. About 90% of phyllodes tumors are benign, and about 10% are malignant. Metastasis of this type of tumor is rare, but it can recur locally and requires surgical resection with wide margins to effectively control local recurrence. 7. Rare tumors include squamous cell carcinoma, lymphoma and sarcoma. |
<<: What are the ways to check for breast cancer
>>: How to detect breast cancer
What are the chemotherapy methods for bile duct c...
HER2 positive breast cancer survival 1. In recent...
As a common cancer disease, nasopharyngeal carcin...
The Moringa tree is actually a plant. However, ma...
Early detection of bone tumors has a great impact...
Some friends want to quickly improve their memory...
Vitiligo is the name given to vitiligo in Chinese...
With the continuous improvement of daily living s...
Some people sometimes go home after a day's w...
What are the treatment and examination methods fo...
What are the dietary precautions for patients wit...
As society develops faster and faster, people'...
As we all know, the nose is an important organ in...
Some people find something abnormal around their ...
Everyone knows that many foods are incompatible a...